- Home
- CLLS vs CHN Comparison
CLLS vs CHN Comparison
Compare CLLS & CHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- CHN
- Stock Information
- Founded
- CLLS 1999
- CHN 1992
- Country
- CLLS France
- CHN United States
- Employees
- CLLS N/A
- CHN N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- CHN Investment Managers
- Sector
- CLLS Health Care
- CHN Finance
- Exchange
- CLLS Nasdaq
- CHN Nasdaq
- Market Cap
- CLLS 144.4M
- CHN 128.4M
- IPO Year
- CLLS 2007
- CHN N/A
- Fundamental
- Price
- CLLS $1.49
- CHN $12.41
- Analyst Decision
- CLLS Buy
- CHN
- Analyst Count
- CLLS 3
- CHN 0
- Target Price
- CLLS $6.67
- CHN N/A
- AVG Volume (30 Days)
- CLLS 46.6K
- CHN 31.8K
- Earning Date
- CLLS 05-12-2025
- CHN 01-01-0001
- Dividend Yield
- CLLS N/A
- CHN 0.19%
- EPS Growth
- CLLS N/A
- CHN N/A
- EPS
- CLLS N/A
- CHN N/A
- Revenue
- CLLS $54,747,000.00
- CHN N/A
- Revenue This Year
- CLLS $48.52
- CHN N/A
- Revenue Next Year
- CLLS $5.17
- CHN N/A
- P/E Ratio
- CLLS N/A
- CHN N/A
- Revenue Growth
- CLLS 351.26
- CHN N/A
- 52 Week Low
- CLLS $1.10
- CHN $9.00
- 52 Week High
- CLLS $2.78
- CHN $12.98
- Technical
- Relative Strength Index (RSI)
- CLLS 51.15
- CHN 51.53
- Support Level
- CLLS $1.46
- CHN $12.25
- Resistance Level
- CLLS $1.60
- CHN $12.57
- Average True Range (ATR)
- CLLS 0.08
- CHN 0.24
- MACD
- CLLS -0.01
- CHN -0.01
- Stochastic Oscillator
- CLLS 52.17
- CHN 39.40
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About CHN China Fund Inc. (The)
CHINA FUND INC is a non-diversified, closed-end management investment company. Its investment objective is a long-term capital appreciation which it seeks to achieve by investing in equity securities with trading in China and outside China. It invests in various industries such as Insurance, Entertainment, Machinery, Electrical Equipment, Beverages, Hotels, Restaurants, and Leisure among others.